Portola Pharma (PTLA) to Offer $300M in Common Stock
Tweet Send to a Friend
Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced plans to offer, subject to market and other conditions, $300 million of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
